| 1.3177 -0.002 (-0.17%) | 06-09 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |   |
|||
| Targets | 6-month : | 1.67 | 1-year : | 1.95 |
| Resists | First : | 1.42 | Second : | 1.67 |
| Pivot price | 1.27 |
|||
| Supports | First : | 1.25 | Second : | 1.14 |
| MAs | MA(5) : | 1.27 |
MA(20) : | 1.26 |
| MA(100) : | 1.42 |
MA(250) : | 1.57 |
|
| MACD | MACD : | 0 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 61.7 |
D(3) : | 65.1 |
| RSI | RSI(14): 57.1 |
|||
| 52-week | High : | 3.4 | Low : | 1.12 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ BON ] has closed below upper band by 4.6%. Bollinger Bands are 40.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 1.32 - 1.33 | 1.33 - 1.33 |
| Low: | 1.25 - 1.26 | 1.26 - 1.27 |
| Close: | 1.31 - 1.32 | 1.32 - 1.33 |
Bon Natural Life Limited, accompanied by its various subsidiaries, focuses on the innovation, production, and worldwide distribution of active functional compounds sourced from natural plant extracts. Its operations span the People's Republic of China and international markets. The company's diverse product range includes components for personal care items, such as plant-derived aromatic compounds supplied to manufacturers of perfumes and fragrances. It also develops natural health products, featuring powdered beverages and biologically active food ingredients primarily intended for use as food additives, as well as a variety of nutritional supplements. These offerings are predominantly utilized by industrial clients in the functional food, personal care, cosmetic, and pharmaceutical sectors. Founded in 2006, Bon Natural Life Limited's main office is located in Grand Cayman, Cayman Islands.
Fri, 15 May 2026
Bon Natural Life (BON) director Zhixiang Gao reports Form 3 - Stock Titan
Mon, 04 May 2026
Most and least shorted materials stocks with up to $2B market cap (XLB:NYSEARCA) - Seeking Alpha
Fri, 10 Apr 2026
Bon Natural Life (BON) COO discloses 120 Class A shares via entity - Stock Titan
Sun, 03 Aug 2025
BON | Bon Natural Life Limited Institutional Ownership - Quiver Quantitative
Thu, 31 Jul 2025
BON Natural Life Launches AI-Powered Drug Discovery Platform, Advancing TCM-Based Pharma Innovation - BioPharma APAC
Thu, 15 May 2025
Bon Natural Life Limited Announces Effectiveness of Reverse Stock Split - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Consumer Defensive
|
|
|
Industry:
Packaged Foods
|
|
| Shares Out | 6 (M) |
| Shares Float | 6 (M) |
| Held by Insiders | 1.3 (%) |
| Held by Institutions | 0.2 (%) |
| Shares Short | 28 (K) |
| Shares Short P.Month | 31 (K) |
| EPS | -0.73 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 9.32 |
| Profit Margin | -10.7 % |
| Operating Margin | -17.8 % |
| Return on Assets (ttm) | -1.4 % |
| Return on Equity (ttm) | -4 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0.63 |
| Sales Per Share | 3.06 |
| EBITDA (p.s.) | -0.09 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -6 (M) |
| PE Ratio | -1.84 |
| PEG Ratio | 0 |
| Price to Book value | 0.14 |
| Price to Sales | 0.42 |
| Price to Cash Flow | 56.86 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|